Compare STWD & BCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STWD | BCPC |
|---|---|---|
| Founded | 2009 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Major Chemicals |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 5.4B |
| IPO Year | 2009 | 1995 |
| Metric | STWD | BCPC |
|---|---|---|
| Price | $18.11 | $175.31 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 2 |
| Target Price | $20.13 | ★ $176.00 |
| AVG Volume (30 Days) | ★ 2.9M | 152.3K |
| Earning Date | 05-08-2026 | 04-30-2026 |
| Dividend Yield | ★ 10.58% | 0.55% |
| EPS Growth | 4.55 | ★ 20.87 |
| EPS | 1.15 | ★ 4.75 |
| Revenue | ★ $1,844,289,000.00 | $799,023,000.00 |
| Revenue This Year | $283.44 | $8.47 |
| Revenue Next Year | $17.66 | $4.89 |
| P/E Ratio | ★ $15.78 | $36.69 |
| Revenue Growth | N/A | ★ 13.56 |
| 52 Week Low | $16.90 | $139.17 |
| 52 Week High | $20.99 | $183.90 |
| Indicator | STWD | BCPC |
|---|---|---|
| Relative Strength Index (RSI) | 60.90 | 57.72 |
| Support Level | $17.64 | $167.19 |
| Resistance Level | $18.62 | $177.06 |
| Average True Range (ATR) | 0.25 | 3.28 |
| MACD | 0.12 | 0.78 |
| Stochastic Oscillator | 91.92 | 81.80 |
Starwood Property Trust Inc is a real estate investment trust principally engaged in originating, acquiring, and managing commercial mortgage loans, commercial mortgage-backed securities, and other real estate investments in the U.S., Australia, and Europe. The company has four reportable business segments: Commercial and Residential Lending, Infrastructure Lending, Property, and Investing and Servicing. The majority of its revenue is generated from the Commercial and Residential Lending segment, which engages mainly in originating, acquiring, financing, and managing commercial first mortgages, non-agency residential mortgages (residential loans), commercial mortgage-backed securities (CMBS), residential mortgage-backed securities (RMBS), and other real estate and related debt investments.
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.